Vision Outcomes in Early versus Late Surgical Intervention of Pituitary Apoplexy: Meta-Analysis.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 01 02 2019
revised: 13 03 2019
accepted: 14 03 2019
pubmed: 30 3 2019
medline: 11 1 2020
entrez: 30 3 2019
Statut: ppublish

Résumé

Pituitary apoplexy (PA) is defined by hemorrhage and necrosis of the pituitary gland, often acute in onset, and frequently in the setting of an existing pituitary adenoma. Our objective was to conduct a meta-analysis of the available literature on vision outcomes following surgical intervention for PA on the basis of the timing from apoplexy to surgery (ATS). A thorough literature search of the published English-language literature was performed in PubMed, Ovid, and Cochrane databases using the key words ("pituitary apoplexy") and ("surgery" or "vision") from database inception to August 2018 was conducted. The primary outcome variable evaluated using a binary random-effects model was vision recovery outcomes (metric: odds ratio). Of 234 articles found, 12 articles containing 200 patients met our eligibility criteria. The mean age was 46.1, with a male-to-female ratio of 2.9:1. A total of 86% of PA patients presented with visual deficits (ATS <7 days in 93 and >7 days in 79 patients). In patients with an ATS <7 days, 97.8% experienced visual recovery, compared with 84.8% with an ATS >7 days (odds ratio 2.6 [95% CI 0.94-7.31]; P value = 0.07). Despite readily accepted guidelines provided by the United Kingdom advocating for early surgical intervention in PA, the rates of vision outcomes we report demonstrate >80% recovery for patients in both the early and late surgical intervention group. As such, conservative management may be warranted for early stabilization before surgical intervention in PA patients with respect to vision outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Pituitary apoplexy (PA) is defined by hemorrhage and necrosis of the pituitary gland, often acute in onset, and frequently in the setting of an existing pituitary adenoma. Our objective was to conduct a meta-analysis of the available literature on vision outcomes following surgical intervention for PA on the basis of the timing from apoplexy to surgery (ATS).
METHODS METHODS
A thorough literature search of the published English-language literature was performed in PubMed, Ovid, and Cochrane databases using the key words ("pituitary apoplexy") and ("surgery" or "vision") from database inception to August 2018 was conducted. The primary outcome variable evaluated using a binary random-effects model was vision recovery outcomes (metric: odds ratio).
RESULTS RESULTS
Of 234 articles found, 12 articles containing 200 patients met our eligibility criteria. The mean age was 46.1, with a male-to-female ratio of 2.9:1. A total of 86% of PA patients presented with visual deficits (ATS <7 days in 93 and >7 days in 79 patients). In patients with an ATS <7 days, 97.8% experienced visual recovery, compared with 84.8% with an ATS >7 days (odds ratio 2.6 [95% CI 0.94-7.31]; P value = 0.07).
CONCLUSIONS CONCLUSIONS
Despite readily accepted guidelines provided by the United Kingdom advocating for early surgical intervention in PA, the rates of vision outcomes we report demonstrate >80% recovery for patients in both the early and late surgical intervention group. As such, conservative management may be warranted for early stabilization before surgical intervention in PA patients with respect to vision outcomes.

Identifiants

pubmed: 30922898
pii: S1878-8750(19)30811-3
doi: 10.1016/j.wneu.2019.03.133
pii:
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-57

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ronald Sahyouni (R)

UC Irvine School of Medicine, Orange, California, USA.

Khodayar Goshtasbi (K)

UC Irvine School of Medicine, Orange, California, USA.

Edward Choi (E)

UC Irvine School of Medicine, Orange, California, USA.

Hossein Mahboubi (H)

UC Irvine Department of Otolaryngology-Head and Neck Surgery, Orange, California, USA.

Ryan Le (R)

UC Irvine School of Medicine, Orange, California, USA.

Anadjeet S Khahera (AS)

UC Irvine School of Medicine, Orange, California, USA.

George K Hanna (GK)

UC Irvine Department of Neurological Surgery, Orange, California, USA.

Dustin Hatefi (D)

UC Irvine Department of Neurological Surgery, Orange, California, USA.

Frank P Hsu (FP)

UC Irvine Department of Neurological Surgery, Orange, California, USA.

Naveen D Bhandarkar (ND)

UC Irvine Department of Otolaryngology-Head and Neck Surgery, Orange, California, USA.

Edward C Kuan (EC)

UC Irvine Department of Otolaryngology-Head and Neck Surgery, Orange, California, USA.

Gilbert Cadena (G)

UC Irvine Department of Neurological Surgery, Orange, California, USA. Electronic address: gcadena@uci.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH